Ad is loading...
APYX
Price
$1.45
Change
+$0.03 (+2.11%)
Updated
Nov 22 closing price
110 days until earnings call
AVGR
Price
$0.83
Change
+$0.04 (+5.06%)
Updated
Nov 22 closing price
Ad is loading...

APYX vs AVGR

Header iconAPYX vs AVGR Comparison
Open Charts APYX vs AVGRBanner chart's image
Apyx Medical
Price$1.45
Change+$0.03 (+2.11%)
Volume$41.44K
CapitalizationN/A
Avinger
Price$0.83
Change+$0.04 (+5.06%)
Volume$31.5K
CapitalizationN/A
APYX vs AVGR Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AVGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
APYX vs. AVGR commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a StrongBuy and AVGR is a Sell.

COMPARISON
Comparison
Nov 23, 2024
Stock price -- (APYX: $1.45 vs. AVGR: $0.83)
Brand notoriety: APYX and AVGR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 84% vs. AVGR: 23%
Market capitalization -- APYX: $47.46M vs. AVGR: $5.28M
APYX [@Medical Specialties] is valued at $47.46M. AVGR’s [@Medical Specialties] market capitalization is $5.28M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileAVGR’s FA Score has 1 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • AVGR’s FA Score: 1 green, 4 red.
According to our system of comparison, APYX is a better buy in the long-term than AVGR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish while AVGR’s TA Score has 2 bullish TA indicator(s).

  • APYX’s TA Score: 4 bullish, 6 bearish.
  • AVGR’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both APYX and AVGR are a bad buy in the short-term.

Price Growth

APYX (@Medical Specialties) experienced а +14.68% price change this week, while AVGR (@Medical Specialties) price change was +4.94% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.02%. For the same industry, the average monthly price growth was +0.79%, and the average quarterly price growth was -2.06%.

Reported Earning Dates

APYX is expected to report earnings on Mar 13, 2025.

AVGR is expected to report earnings on Oct 26, 2023.

Industries' Descriptions

@Medical Specialties (+3.02% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APYX($47.5M) has a higher market cap than AVGR($5.28M). APYX YTD gains are higher at: -44.847 vs. AVGR (-69.410). AVGR has higher annual earnings (EBITDA): -16.35M vs. APYX (-18.11M). APYX has more cash in the bank: 43.7M vs. AVGR (5.28M). AVGR has less debt than APYX: AVGR (15.4M) vs APYX (38.5M). APYX has higher revenues than AVGR: APYX (52.3M) vs AVGR (7.65M).
APYXAVGRAPYX / AVGR
Capitalization47.5M5.28M900%
EBITDA-18.11M-16.35M111%
Gain YTD-44.847-69.41065%
P/E RatioN/AN/A-
Revenue52.3M7.65M683%
Total Cash43.7M5.28M828%
Total Debt38.5M15.4M250%
FUNDAMENTALS RATINGS
APYX vs AVGR: Fundamental Ratings
APYX
AVGR
OUTLOOK RATING
1..100
2060
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4992
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AVGR's Valuation (28) in the Medical Specialties industry is in the same range as APYX (56). This means that AVGR’s stock grew similarly to APYX’s over the last 12 months.

AVGR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as APYX (100). This means that AVGR’s stock grew similarly to APYX’s over the last 12 months.

APYX's SMR Rating (98) in the Medical Specialties industry is in the same range as AVGR (100). This means that APYX’s stock grew similarly to AVGR’s over the last 12 months.

APYX's Price Growth Rating (49) in the Medical Specialties industry is somewhat better than the same rating for AVGR (92). This means that APYX’s stock grew somewhat faster than AVGR’s over the last 12 months.

APYX's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as AVGR (100). This means that APYX’s stock grew similarly to AVGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXAVGR
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
APYX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
AVGR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE3.030.13
+4.48%
VYNE Therapeutics
GRFS8.700.16
+1.87%
Grifols SA
ADSK321.275.86
+1.86%
Autodesk
AIP8.37-0.08
-0.95%
Arteris
FINV6.18-0.11
-1.75%
FinVolution Group

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
+1.76%
CORBF - APYX
36%
Loosely correlated
N/A
MKEAF - APYX
33%
Loosely correlated
N/A
AVGR - APYX
27%
Poorly correlated
+5.07%
WRBY - APYX
24%
Poorly correlated
-0.69%
INMD - APYX
23%
Poorly correlated
+2.89%
More

AVGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVGR has been loosely correlated with IMTH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AVGR jumps, then IMTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVGR
1D Price
Change %
AVGR100%
+5.07%
IMTH - AVGR
34%
Loosely correlated
N/A
APYX - AVGR
27%
Poorly correlated
+1.76%
MTD - AVGR
27%
Poorly correlated
+1.77%
MBOT - AVGR
27%
Poorly correlated
+5.41%
VTAK - AVGR
25%
Poorly correlated
-0.94%
More